EJR IS INDEXED IN WEB OF SCIENCE AND PUBMED CENTRAL
European Journal of Rheumatology
  1. Home
  2. Remembering visceral leishmani...
Letter to the Editor

Remembering visceral leishmaniasis as a potential trigger of haemophagocytic lymphohistiocytosis in individuals treated with anti-TNF-alpha therapy

Amina Nardo-Marino 1 , Katrine Bukan 2 , Henrik Vedel Nielsen 3 , Daniel El Fassi 4
1.

Department of Haematology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark

2.

Department of Haematology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark; Department of Nephrology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark

3.

Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark

4.

Department of Haematology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark; Department of Rheumatology, Rigshospitalet, Institute for Inflammation Research, Copenhagen University Hospital, Copenhagen, Denmark

Eur J Rheumatol 2019; 6: 226-227
DOI: 10.5152/eurjrheum.2019.18178
Read: 2410 Downloads: 1266 Published: 16 October 2019
Volume 6, Issue 4, October 2019
Previous Article Next Article

Cite this article as: Nardo-Marino A, Bukan K, Vedel Nielsen H, El Fassi D. Remembering visceral leishmaniasis as a potential trigger of haemophagocytic lymphohistiocytosis in individuals treated with anti-TNF-alpha therapy. Eur J Rheumatol 2019; 6(4): 226-7.

Files
Full Text PDF
EISSN 2148-4279